| Variant class | Representative variant(s) | ClinVar ID / identifier | Primary molecular mechanism | Effect on CRX protein function | Mouse / model phenotype | Associated human phenotype(s) |
|---|---|---|---|---|---|---|
| Truncated effector-domain variants | E168d2; human c.503_504del (p.Glu168fs) | VCV000099609 for E168d2 | Premature termination in the C-terminal transcription effector domain; mutant transcript/protein overexpression increases mutant:wild-type ratio, producing a dominant-negative effect in which mutant CRX outcompetes WT CRX at cognate regulatory sites (pqac-00000024, pqac-00000032) | DNA-binding domain remains intact, but transcriptional activation is defective/incompetent because the effector domain is truncated; downstream photoreceptor gene activation is impaired (pqac-00000008, pqac-00000024) | E168d2/+ mice have 6-8 ONL rows by 3 months, no detectable cone function, severely impaired rod function by 1 month, and complete rod function loss by 3 months; E168d2/d2 mice retain only 3-4 ONL rows by 1 month and never develop visual function (pqac-00000024, pqac-00000032) | Dominant Leber congenital amaurosis (LCA7); severe early-onset retinal degeneration (pqac-00000002, pqac-00000032) |
| Extended effector-domain variants | CrxRip; spontaneous c.763del (p.Gly255Alafs*133) | No ClinVar ID stated in gathered evidence | Frameshift creates an elongated mutant CRX with partial effector domain plus non-homologous C-terminal extension; altered residue composition likely perturbs recruitment specificity/affinity for transcriptional cofactors and mediators, causing genome-wide misregulation (pqac-00000024, pqac-00000025) | DNA-binding domain is preserved, but the altered/extended effector domain disrupts transcriptional regulation; proposed loss of OTX tail function and abnormal cofactor recruitment antagonize WT CRX (pqac-00000024, pqac-00000025) | Rip/+ mice are completely blind at 1 month, yet ONL thickness is largely preserved up to at least 18 months, indicating profound functional impairment and incomplete differentiation without rapid structural degeneration (pqac-00000024, pqac-00000032) | Congenital blindness / LCA-like CRX-associated retinopathy; class exemplifies severe functional deficit with relatively preserved retinal thickness early on (pqac-00000016, pqac-00000032) |
| Hypomorphic missense variants reducing DNA-binding affinity | R90W (p.Arg90Trp); also R40, R41, R43 class variants | VCV000007422 for R90W | Reduced homeodomain DNA-binding affinity lowers CRX target-gene activation; severity generally tracks with the degree of deviation from wild-type DNA binding strength (pqac-00000009, pqac-00000031) | CRX binds cognate DNA poorly and transactivates photoreceptor promoters weakly; R90 contributes structural stabilization of the HD-DNA complex rather than direct base contact (pqac-00000009, pqac-00000031) | CrxR90W/W mice resemble Crx knockout photoreceptor degeneration phenotypes; loss of photoreceptor differentiation/function is consistent with markedly reduced DNA binding (pqac-00000025, pqac-00000031) | Recessive LCA and mild late-onset dominant cone-rod dystrophy; R40/R41/R43 variants are linked to more severe dominant retinal dystrophies (pqac-00000002, pqac-00000031) |
| Antimorphic missense variants altering DNA-binding specificity / selectivity | E80A (p.Glu80Ala); K88N (p.Lys88Asn) | VCV000007416 for E80A; no ClinVar ID stated here for K88N | Gain-of-function / antimorphic mechanisms. E80A preserves preference for CRX sites but reduces selectivity, promoting promiscuous binding and hyperactivation of early target genes; K88N alters DNA-binding specificity, redirecting CRX to ectopic non-cognate sites (pqac-00000009, pqac-00000014) | E80A causes elevated transactivation at WT and suboptimal motifs; K88N changes preferred DNA sequence recognition from canonical CRX motifs toward alternative motifs, severely perturbing gene-expression programs (pqac-00000009, pqac-00000014) | E80A/+ mice show no detectable cone-mediated responses, defective rod-mediated responses at 1 month, shortened/disorganized outer segments and ONL disorganization, but no obvious early photoreceptor degeneration; knock-in studies of E80A and K88N demonstrate severe dominant retinopathy through distinct gain-of-function mechanisms (pqac-00000009, pqac-00000004) | Severe early-onset dominant cone-rod dystrophy for E80A; severe dominant retinopathies including LCA/CoRD spectrum for E80A and K88N (pqac-00000000, pqac-00000002, pqac-00000004) |


*Table: This table summarizes the four major CRX pathogenic variant classes described in recent literature, linking representative mutations to molecular mechanisms, functional consequences, model phenotypes, and human disease presentations. It is useful for understanding genotype-mechanism-phenotype relationships across CRX-associated retinopathies.*